For following the competition: what moved in each program, several studies read as one move.
- revakinagene taroretcel
- Ciliary Neurotrophic Factor
- AKT1 E17K Inhibitor ATV-1601
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Telangiectasis to watchlistEvery Monday by email · turn it off any timePro · free during the beta